Charles Ugochukwu Ibeneme
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Charles Ugochukwu Ibeneme has a total of 76 co-authors. Here are the top co-authors by number of shared publications:
- Beryl Njeba
World Health Organisation Regional Office for Africa, Brazzaville, Congo
2 shared publications Jean Kaseya
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
2 shared publications- Kyeng Mercy
Africa Centres for Disease Control and Prevention
2 shared publications - Mamadou Saliou Kalifa Diallo
EPR, World Health Organization Regional Office for Africa, Brazzaville, Congo
2 shared publications - Nebiyu Dereje
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
2 shared publications Ngashi Ngongo
Africa Centres for Disease Control and Prevention, Addis Ababa, Ethiopia
2 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (9) , e023050
Mpox in Africa: one year continental response outcomes and way forward
Background: Following the declaration of mpox as both a global and continental public health emergency in August 2024, the Joint Incident Management Support Team (IMST), co-led by the Africa Centres for Disease Control and Prevention (Africa CDC) and the WHO, was activated in Kinshasa, DRC to coordinate the continental mpox response. This article highlights the first year’s epidemiological and operational findings. Methods: Key performance indicators across eight IMST pillars (coordination, surveillance, laboratory, case management, infection prevention and control, risk communication and community engagement (RCCE), vaccination and research) were descriptively analysed using data from 28 African Union Member States from January 2024 to August 2025. Results: A total of 49 803 confirmed cases and 240 deaths (CFR 0.5%) were recorded across 28 countries. The response was supported with US$977 million as tracked by the IMST. Operational achievements included 87% surveillance completeness, 72% contact tracing completeness and improved average laboratory turnaround time from >5 days to 2 days. Laboratory testing capacity expanded from 2 to 27 sites in the DRC and from 1 to 56 decentralised sites in Burundi. RCCE activities reached 50 million people in 21 countries, with vaccine acceptance among high-risk groups rising from 44% to 87%. Operational research achievements included a responsive and functional research coordination mechanism, 24 (92%, 24/26) multi-country clinical and operational research studies implemented and 60% completion rate of the research data and material sharing framework for Africa. Only 938 000 doses (32%) of the 3.1 million vaccine doses delivered were administered. Conclusion: The joint continental IMST is a new benchmark for response governance, successfully mobilising resources and scaling up diagnostics under unified co-leadership. On the other hand, the evaluation revealed persistent structural challenges in last-mile vaccine delivery, contact tracing (due to stigma/funding) and weak regional collaborative research including fragmented regional research priorities. Future focus must shift from emergency action to durable, sustained investment in national and sub-national health security architecture using a multisectoral whole of government approach.
- 15 September 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (9) , e023050
Open AccessMpox in Africa: one year continental response outcomes and way forward
Background: Following the declaration of mpox as both a global and continental public health emergency in August 2024, the Joint Incident Management Support Team (IMST), co-led by the Africa Centres for Disease Control and Prevention (Africa CDC) and the WHO, was activated in Kinshasa, DRC to coordinate the continental mpox response. This article highlights the first year’s epidemiological and operational findings. Methods: Key performance indicators across eight IMST pillars (coordination, surveillance, laboratory, case management, infection prevention and control, risk communication and community engagement (RCCE), vaccination and research) were descriptively analysed using data from 28 African Union Member States from January 2024 to August 2025. Results: A total of 49 803 confirmed cases and 240 deaths (CFR 0.5%) were recorded across 28 countries. The response was supported with US$977 million as tracked by the IMST. Operational achievements included 87% surveillance completeness, 72% contact tracing completeness and improved average laboratory turnaround time from >5 days to 2 days. Laboratory testing capacity expanded from 2 to 27 sites in the DRC and from 1 to 56 decentralised sites in Burundi. RCCE activities reached 50 million people in 21 countries, with vaccine acceptance among high-risk groups rising from 44% to 87%. Operational research achievements included a responsive and functional research coordination mechanism, 24 (92%, 24/26) multi-country clinical and operational research studies implemented and 60% completion rate of the research data and material sharing framework for Africa. Only 938 000 doses (32%) of the 3.1 million vaccine doses delivered were administered. Conclusion: The joint continental IMST is a new benchmark for response governance, successfully mobilising resources and scaling up diagnostics under unified co-leadership. On the other hand, the evaluation revealed persistent structural challenges in last-mile vaccine delivery, contact tracing (due to stigma/funding) and weak regional collaborative research including fragmented regional research priorities. Future focus must shift from emergency action to durable, sustained investment in national and sub-national health security architecture using a multisectoral whole of government approach.
- Open Access
- 3 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 5282
The need for sustaining mpox vaccination in Africa
Sustaining and transitioning mpox vaccination requires establishing and resourcing a global mpox vaccine stockpile under the Inter-Agency Coordinating Group (ICG), supported by sustainable financing, transparent allocation criteria, diversified manufacturing (including local production in Africa), and robust logistics, surveillance, and operational systems. Moreover, it requires strengthened collaboration among global, regional, and community actors; continuous data generation and research to inform policy, including genomic and vaccine effectiveness studies; and accelerated R&D with fast-tracked local manufacturing to enhance supply resilience and long-term epidemic preparedness.
- 3 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 5282
Open AccessThe need for sustaining mpox vaccination in Africa
Sustaining and transitioning mpox vaccination requires establishing and resourcing a global mpox vaccine stockpile under the Inter-Agency Coordinating Group (ICG), supported by sustainable financing, transparent allocation criteria, diversified manufacturing (including local production in Africa), and robust logistics, surveillance, and operational systems. Moreover, it requires strengthened collaboration among global, regional, and community actors; continuous data generation and research to inform policy, including genomic and vaccine effectiveness studies; and accelerated R&D with fast-tracked local manufacturing to enhance supply resilience and long-term epidemic preparedness.
- Open Access
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (4) , 3
Africa’s second plan to stop mpox outbreaks through intensification, integration, and legacy
The Journal of Public Health in Africa (JPHiA) is a peer-reviewed, academic journal that focuses on health issues in the African continent. The journal editors seek high quality original articles on public health related issues, reviews, comments and more. The aim of the journal is to move public health discourse from the background to the forefront. The success of Africa’s struggle against disease depends on public health approaches.
- 1 January 2025
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 16 (4) , 3
Open AccessAfrica’s second plan to stop mpox outbreaks through intensification, integration, and legacy
The Journal of Public Health in Africa (JPHiA) is a peer-reviewed, academic journal that focuses on health issues in the African continent. The journal editors seek high quality original articles on public health related issues, reviews, comments and more. The aim of the journal is to move public health discourse from the background to the forefront. The success of Africa’s struggle against disease depends on public health approaches.